Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Ciena Corporation is a communication equipment business based in the US. Ciena Corporation shares (CIEN) are listed on the NYSE and all prices are listed in US Dollars. Ciena Corporation employs 7,251 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$52.67|
|52-week range||$38.03 - $61.09|
|50-day moving average||$52.82|
|200-day moving average||$54.99|
|Wall St. target price||$66.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.95|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||0.80%|
|1 month (2021-09-24)||1.25%|
|3 months (2021-07-23)||-6.30%|
|6 months (2021-04-23)||-3.29%|
|1 year (2020-10-23)||27.72%|
|2 years (2019-10-24)||42.78%|
|3 years (2018-10-24)||77.76%|
|5 years (2016-10-24)||162.69%|
Valuing Ciena Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ciena Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ciena Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Ciena Corporation shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Ciena Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.77. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ciena Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ciena Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $578.2 million.
The EBITDA is a measure of a Ciena Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.4 billion|
|Operating margin TTM||13.08%|
|Gross profit TTM||$1.7 billion|
|Return on assets TTM||6.4%|
|Return on equity TTM||17.25%|
|Market capitalisation||$8.2 billion|
TTM: trailing 12 months
There are currently 4.1 million Ciena Corporation shares held short by investors – that's known as Ciena Corporation's "short interest". This figure is 6.3% up from 3.9 million last month.
There are a few different ways that this level of interest in shorting Ciena Corporation shares can be evaluated.
Ciena Corporation's "short interest ratio" (SIR) is the quantity of Ciena Corporation shares currently shorted divided by the average quantity of Ciena Corporation shares traded daily (recently around 1.4 million). Ciena Corporation's SIR currently stands at 3. In other words for every 100,000 Ciena Corporation shares traded daily on the market, roughly 3000 shares are currently held short.
However Ciena Corporation's short interest can also be evaluated against the total number of Ciena Corporation shares, or, against the total number of tradable Ciena Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ciena Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Ciena Corporation shares in existence, roughly 30 shares are currently held short) or 0.0269% of the tradable shares (for every 100,000 tradable Ciena Corporation shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ciena Corporation.
Find out more about how you can short Ciena Corporation stock.
We're not expecting Ciena Corporation to pay a dividend over the next 12 months.
Ciena Corporation's shares were split on a 1:7 basis on 24 September 2006. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ciena Corporation shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Ciena Corporation shares which in turn could have impacted Ciena Corporation's share price.
Over the last 12 months, Ciena Corporation's shares have ranged in value from as little as $38.03 up to $61.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ciena Corporation's is 0.864. This would suggest that Ciena Corporation's shares are less volatile than average (for this exchange).
Ciena Corporation provides network hardware, software, and services that support the transport, routing, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks worldwide. The company's Networking Platforms segment offers hardware networking products and solutions that optimized for the convergence of coherent optical transport, optical transport network switching, and packet switching. Its products include 6500 Packet-Optical Platform, 5430 Reconfigurable Switching System, Waveserver stackable interconnect system, and the 6500 Reconfigurable line system, and the 5400 family of Packet-Optical platforms, as well as Z-Series Packet-Optical Platform; 3000 family of service delivery switches and service aggregation switches, and the 5000 family of service aggregation switches, as well as 8700 Packetwave Platform and the Ethernet packet configuration for the 5410 Service Aggregation Switch; and 6500 Packet Transport System. This segment also sells operating system software and enhanced software features embedded in each of its products. The company's Blue Planet Automation Software and Services segment provides multi-domain service orchestration, inventory, route optimization and analysis, network function virtualization orchestration, analytics, and related services. Its Platform Software and Service segment offers OneControl unified management system and platform software services, as well as manage, control, and plan software. The company's Global Services segment provides consulting and network design, installation and deployment, maintenance support, and training services.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.